Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine.
Cusano
Francesco
F
Dermatology Unit, Gaetano Rummo General Hospital, Benevento, Italy. francesco.cusano@ao-rummo.it
Ferrara
Gerardo
G
Crisman
Giuliana
G
Sarracco
Giovanni
G
Zalaudek
Iris
I
Argenziano
Giuseppe
G
D000485:Allergens / Q000009:adverse effects*; D018926:Anti-Allergic Agents / Q000009:adverse effects*; D017332:Cetirizine / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology*; D005029:Ethylenediamines / Q000009:adverse effects*; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*
D000485:Allergens; D018926:Anti-Allergic Agents; D005029:Ethylenediamines; D039563:Histamine H1 Antagonists, Non-Sedating; D010879:Piperazines; C031234:ethylenediamine; C472067:levocetirizine; D017332:Cetirizine